Cole F S, Matthews W J, Rossing T H, Gash D J, Lichtenberg N A, Pennington J E
Clin Immunol Immunopathol. 1983 May;27(2):153-9. doi: 10.1016/0090-1229(83)90065-x.
Complement production by bronchoalveolar macrophages recovered from 8 normal volunteers and 15 patients with a variety of lung diseases was measured functionally and immunochemically. While macrophages from all eight normals demonstrated the capacity to secrete hemolytically active C2 and factor B within 48 hr of culture at consistent rates, bronchoalveolar macrophages from patients secreted C2 and factor B in widely differing amounts, and in some cases, not at all. No functional, secreted C3 was detected from normal macrophage monolayers, although apparently native C3 protein was synthesized and secreted. In contrast, functional C3 was produced by macrophage monolayers from 3 of 15 patients. These findings suggest that complement production by the normal human bronchoalveolar macrophage differs from its progenitor cell, the blood monocyte, and that complement production by bronchoalveolar macrophages may be altered in different pulmonary diseases.
对从8名正常志愿者和15名患有各种肺部疾病的患者中获取的支气管肺泡巨噬细胞的补体生成进行了功能和免疫化学测定。虽然所有8名正常人的巨噬细胞在培养48小时内均表现出以一致速率分泌具有溶血活性的C2和B因子的能力,但患者的支气管肺泡巨噬细胞分泌C2和B因子的量差异很大,在某些情况下甚至完全不分泌。正常巨噬细胞单层未检测到有功能的分泌型C3,尽管显然合成并分泌了天然C3蛋白。相比之下,15名患者中有3名患者的巨噬细胞单层产生了有功能的C3。这些发现表明,正常人支气管肺泡巨噬细胞的补体生成不同于其祖细胞——血液单核细胞,并且支气管肺泡巨噬细胞的补体生成在不同的肺部疾病中可能会发生改变。